Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 5/20 | 0.43 |
| ▸ | RAB9A | P51151 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.42 |
| ▸ | STAT1 | P42224 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.36 |
| ▸ | LDHB | P07195 | 1/20 | 0.36 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14060191 | 0.90 | SMN1; SMN2 (0.44) | ALDH1A1TSHRNPC1RAB9AKDM4E | |
| SCHEMBL14118840 | 0.88 | ALDH1A1 (0.49) | ALDH1A1TSHRNPC1RAB9AKDM4E | |
| SCHEMBL51038 | 0.83 | ALDH1A1 (0.55) | ALDH1A1TSHRNPC1RAB9AKDM4E | |
| SCHEMBL18740423 | 0.83 | ALDH1A1 (0.47) | ALDH1A1TSHRNPC1RAB9AKDM4E | |
| SCHEMBL19226105 | 0.83 | ELANE (0.50) | ALDH1A1TSHR | |
| SCHEMBL18640566 | 0.83 | ELANE (0.50) | ALDH1A1TSHR | |
| SCHEMBL18640548 | 0.83 | ELANE (0.50) | ALDH1A1TSHR | |
| SCHEMBL19226024 | 0.83 | ELANE (0.50) | ALDH1A1TSHR | |
| SCHEMBL21854812 | 0.83 | ELANE (0.50) | ALDH1A1TSHR | |
| SCHEMBL19226025 | 0.83 | ELANE (0.50) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112830916-B | Preparation method of 2, 5-furandicarboxylic acid under mild condition | 中国科学院宁波材料技术与工程研究所 | 2021-08-13 | — | — | CN | claimed |
| CN-112830916-A | Preparation method of 2, 5-furandicarboxylic acid under mild condition | 中国科学院宁波材料技术与工程研究所 | 2021-05-25 | — | — | CN | claimed |
| EP-3653612-B1 | METHOD FOR PRODUCING PURIFIED DIALKYL-FURAN-2,5-DICARBOXYLATE BY PHYSICAL SEPARATION AND SOLID LIQUID SEPARATION | EASTMAN CHEM CO (US) | 2024-01-17 | — | — | EP | disclosed |
| EP-3578552-B1 | AN OXIDATION PROCESS TO PRODUCE A PURIFIED CARBOXYLIC ACID PRODUCT VIA SOLVENT DISPLACEMENT AND POST OXIDATION | EASTMAN CHEM CO (US) | 2023-06-07 | — | — | EP | disclosed |
| US-11655227-B2 | Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant | EASTMAN CHEMICAL COMPANY (US) | 2023-05-23 | — | — | US | disclosed |
| US-11655227-B2 | Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant | EASTMAN CHEMICAL COMPANY (US) | 2023-05-23 | — | — | US | disclosed |
| WO-2023014553-A1 | INTEGRATED PROCESS FOR 5-(METHOXYCARBONYL)FURAN-2-CARBOXYLIC ACID (MCFC) | EASTMAN CHEMICAL COMPANY (US) | 2023-02-09 | — | — | WO | disclosed |
| WO-2022245625-A1 | PURGE PROCESS FOR 5-(METHOXYCARBONYL)FURAN-2-CARBOXYLIC ACID (MCFC) | EASTMAN CHEMICAL COMPANY (US) | 2022-11-24 | — | — | WO | disclosed |
| EP-3321260-B1 | COMPOSITION OBTAINED BY PURIFYING CRUDE FURAN 2,5-DICARBOXYLIC ACID BY HYDROGENATION | EASTMAN CHEM CO (US) | 2022-07-13 | — | — | EP | disclosed |
| CN-112830916-B | Preparation method of 2, 5-furandicarboxylic acid under mild condition | 中国科学院宁波材料技术与工程研究所 | 2021-08-13 | — | — | CN | disclosed |
| US-11066376-B2 | Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant | EASTMAN CHEMICAL COMPANY (US) | 2021-07-20 | — | — | US | disclosed |
| WO-2009076627-A2 | CONVERSION OF CARBOHYDRATES TO HYDROXY-METHYLFURFURAL (HMF) AND DERIVATIVES | ARCHER DANIELS MIDLAND CO (US) | 2009-06-18 | — | — | WO | disclosed |
| WO-2009076627-A2 | CONVERSION OF CARBOHYDRATES TO HYDROXY-METHYLFURFURAL (HMF) AND DERIVATIVES | ARCHER DANIELS MIDLAND CO (US) | 2009-06-18 | — | — | WO | disclosed |
| US-20090156841-A1 | CONVERSION OF CARBOHYDRATES TO HYDROXYMETHYLFURFURAL (HMF) AND DERIVATIVES | ARCHER DANIELS MIDLAND CO. | 2009-06-18 | — | — | US | disclosed |
| US-20090156841-A1 | CONVERSION OF CARBOHYDRATES TO HYDROXYMETHYLFURFURAL (HMF) AND DERIVATIVES | ARCHER DANIELS MIDLAND CO. | 2009-06-18 | — | — | US | disclosed |
| US-20090156841-A1 | CONVERSION OF CARBOHYDRATES TO HYDROXYMETHYLFURFURAL (HMF) AND DERIVATIVES | ARCHER DANIELS MIDLAND CO. | 2009-06-18 | — | — | US | disclosed |
| CN-101421259-A | Synthesis method and application of 5-hydroxymethylfurfural organic acid ester | FURANIX TECHNOLOGIES BV (NL) | 2009-04-29 | — | — | CN | disclosed |
| WO-2009030512-A2 | HYDROXYMETHYLFURFURAL ETHERS AND ESTERS PREPARED IN IONIC LIQUIDS | FURANIX TECHNOLOGIES B.V. (NL) | 2009-03-12 | — | — | WO | disclosed |
| EP-2001859-A1 | METHOD FOR THE SYNTHESIS OF ORGANIC ACID ESTERS OF 5-HYDROXYMETHYLFURFURAL AND THEIR USE | Furanix Technologies B.V (NL) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007104515-A1 | METHOD FOR THE SYNTHESIS OF ORGANIC ACID ESTERS OF 5-HYDROXYMETHYLFURFURAL AND THEIR USE | FURANIX TECHNOLOGIES B.V. (NL) | 2007-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11066376-B2 | Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant | DDC, DLAT, FDFT1 | ALDH1A1 127/4885TSHR 3251/4885NPC1 2618/4885 |
| US-20090156841-A1 | CONVERSION OF CARBOHYDRATES TO HYDROXYMETHYLFURFURAL (HMF) AND DERIVATIVES | HPD, FOS, MCCC2 | ALDH1A1 953/4885TSHR 3037/4885NPC1 1602/4885 |
| US-11655227-B2 | Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant | DDC, DLAT, FDFT1 | ALDH1A1 127/4885TSHR 3251/4885NPC1 2618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.